These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34163003)

  • 1. A blood-based transcriptomic signature for noninvasive diagnosis of gastric cancer.
    Lee IS; Ahn J; Kim K; Okugawa Y; Toiyama Y; Hur H; Goel A
    Br J Cancer; 2021 Sep; 125(6):846-853. PubMed ID: 34163003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer.
    Roy S; Kanda M; Nomura S; Zhu Z; Toiyama Y; Taketomi A; Goldenring J; Baba H; Kodera Y; Goel A
    Mol Cancer; 2022 Feb; 21(1):42. PubMed ID: 35139874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptomic Profiling Identifies a Risk Stratification Signature for Predicting Peritoneal Recurrence and Micrometastasis in Gastric Cancer.
    Lee IS; Lee H; Hur H; Kanda M; Yook JH; Kim BS; Woo Y; Kodera Y; Kim K; Goel A
    Clin Cancer Res; 2021 Apr; 27(8):2292-2300. PubMed ID: 33558424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and validation of an expression signature for recurrence prediction in high-risk diffuse-type gastric cancer.
    Lee IS; Sahu D; Hur H; Yook JH; Kim BS; Goel A
    Gastric Cancer; 2021 May; 24(3):655-665. PubMed ID: 33523340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and Validation of Salivary Extracellular RNA Biomarkers for Noninvasive Detection of Gastric Cancer.
    Li F; Yoshizawa JM; Kim KM; Kanjanapangka J; Grogan TR; Wang X; Elashoff DE; Ishikawa S; Chia D; Liao W; Akin D; Yan X; Lee MS; Choi R; Kim SM; Kang SY; Bae JM; Sohn TS; Lee JH; Choi MG; Min BH; Lee JH; Kim JJ; Kim Y; Kim S; Wong DTW
    Clin Chem; 2018 Oct; 64(10):1513-1521. PubMed ID: 30097497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
    Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
    Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
    [No Abstract]   [Full Text] [Related]  

  • 7. A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients.
    Guo X; Peng Y; Song Q; Wei J; Wang X; Ru Y; Xu S; Cheng X; Li X; Wu D; Chen L; Wei B; Lv X; Ji G
    Gastroenterology; 2023 Aug; 165(2):402-413.e13. PubMed ID: 36894035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the Diagnostic Efficiency of a Liquid Biopsy Assay for Early Detection of Gastric Cancer.
    Izumi D; Zhu Z; Chen Y; Toden S; Huo X; Kanda M; Ishimoto T; Gu D; Tan M; Kodera Y; Baba H; Li W; Chen J; Wang X; Goel A
    JAMA Netw Open; 2021 Aug; 4(8):e2121129. PubMed ID: 34427680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel urinary microRNA biomarker panel for detecting gastric cancer.
    Iwasaki H; Shimura T; Yamada T; Okuda Y; Natsume M; Kitagawa M; Horike SI; Kataoka H
    J Gastroenterol; 2019 Dec; 54(12):1061-1069. PubMed ID: 31240436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomewide Expression Profiling Identifies a Novel miRNA-based Signature for the Detection of Peritoneal Metastasis in Patients With Gastric Cancer.
    Shimura T; Toden S; Kandimalla R; Toiyama Y; Okugawa Y; Kanda M; Baba H; Kodera Y; Kusunoki M; Goel A
    Ann Surg; 2021 Nov; 274(5):e425-e434. PubMed ID: 31663973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer.
    Huo J; Wu L; Zang Y
    J Immunol Res; 2021; 2021():5554342. PubMed ID: 34007851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A liquid biopsy signature for predicting early recurrence in patients with gastric cancer.
    Okuno K; Watanabe S; Roy S; Kanda M; Tokunaga M; Kodera Y; Kinugasa Y; Goel A
    Br J Cancer; 2023 Apr; 128(6):1105-1116. PubMed ID: 36631634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel urinary protein biomarker panel for early diagnosis of gastric cancer.
    Shimura T; Dayde D; Wang H; Okuda Y; Iwasaki H; Ebi M; Kitagawa M; Yamada T; Yamada T; Hanash SM; Taguchi A; Kataoka H
    Br J Cancer; 2020 Nov; 123(11):1656-1664. PubMed ID: 32934343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum microRNA panel excavated by machine learning as a potential biomarker for the detection of gastric cancer.
    Huang Y; Zhu J; Li W; Zhang Z; Xiong P; Wang H; Zhang J
    Oncol Rep; 2018 Mar; 39(3):1338-1346. PubMed ID: 29286167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide identification of a novel miRNA-based signature to predict recurrence in patients with gastric cancer.
    Yang Y; Qu A; Zhao R; Hua M; Zhang X; Dong Z; Zheng G; Pan H; Wang H; Yang X; Zhang Y
    Mol Oncol; 2018 Dec; 12(12):2072-2084. PubMed ID: 30242969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum miR-515-3p, a potential new RNA biomarker, is involved in gastric carcinoma.
    Han X; Li X; Zhao H; Zhou D; Sun B; Liu A; Zhang J; Cui Z; Ma X; Yuan L
    J Cell Biochem; 2019 Sep; 120(9):15834-15843. PubMed ID: 31081157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel 10 immune-related genes signature as a prognostic biomarker panel for gastric cancer.
    Chen T; Yang C; Dou R; Xiong B
    Cancer Med; 2021 Sep; 10(18):6546-6560. PubMed ID: 34382341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients.
    Toiyama Y; Tanaka K; Kitajima T; Shimura T; Imaoka H; Mori K; Okigami M; Yasuda H; Okugawa Y; Saigusa S; Ohi M; Inoue Y; Mohri Y; Goel A; Kusunoki M
    Carcinogenesis; 2015 Dec; 36(12):1474-83. PubMed ID: 26420253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically applicable 53-Gene prognostic assay predicts chemotherapy benefit in gastric cancer: A multicenter study.
    Zhu L; Wang H; Jiang C; Li W; Zhai S; Cai X; Wang X; Liao L; Tao F; Jin D; Chen G; Xia Y; Mao JH; Li B; Wang P; Hang B
    EBioMedicine; 2020 Nov; 61():103023. PubMed ID: 33069062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomics-based liquid biopsy panel for early non-invasive identification of peritoneal recurrence and micrometastasis in locally advanced gastric cancer.
    Ding P; Wu H; Wu J; Li T; Gu R; Zhang L; Yang P; Guo H; Tian Y; He J; Yang J; Meng N; Li X; Meng L; Zhao Q
    J Exp Clin Cancer Res; 2024 Jun; 43(1):181. PubMed ID: 38937855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.